Studies of pharmacist interventions during comprehensive medication reviews, the impact of new tools to aid drug selection from a hospital formulary, and a project ensuring that hospital patients receiving anti-clotting drugs are properly educated upon discharge took top honors at the Department of Clinical Pharmacy 17th Annual Spring Research Seminar.
The UCSF School of Pharmacy held its 2015 commencement on May 8 at Louise Davies Symphony Hall in San Francisco, conferring doctor of pharmacy (PharmD) degrees on a 125-member graduating class.
Addressing the large gathering including hundreds of graduates’ friends and family members, School faculty on stage, and specially invited guests, Dean B. Joseph Guglielmo, PharmD, remarked on the notable diversity of the graduates, more than a quarter of whom were born in other nations.
Zev Gartner, PhD, has received tenure and advanced to the position of associate professor. Researchers in the Gartner Lab study mammalian cell-cell interactions, with an emphasis on how tissue structure serves to organize cell-cell interactions in vivo. They work entirely on cell-cell interactions relevant to human biology, using the human breast as a model tissue.
Danica Galonić Fujimori, PhD, has received tenure and advanced to the position of associate professor. She holds a joint appointment with the Departments of Pharmaceutical Chemistry and Cellular and Molecular Pharmacology. Fujimori’s research is centered on the enzymology and cellular roles of post-translational methylation.
The annual UCSF School of Pharmacy Student Awards and Recognition Dinner, hosted by Dean B. Joseph Guglielmo, PharmD, and sponsored by Ralph’s Inc., was held on Friday, May 1, 2015, at UCSF’s Mission Bay campus.
The event honored dozens of students whose excellence and leadership were recognized at the campus, state, and national levels with scholarships and awards. The following is a brief selection from the evening’s presentations.
"Predicting Risk in the Development of New Chemical Entities"
T. Vincent Shankey, PhD
R&D Director, Aseda Sciences
Aseda Sciences is small startup service business that has developed a platform that enables or facilitates "fail fast" strategies for early drug discovery
